JPS60231699A - 正常及び悪性ヒト造血器細胞に対するモノクローナル抗体 - Google Patents

正常及び悪性ヒト造血器細胞に対するモノクローナル抗体

Info

Publication number
JPS60231699A
JPS60231699A JP58210381A JP21038183A JPS60231699A JP S60231699 A JPS60231699 A JP S60231699A JP 58210381 A JP58210381 A JP 58210381A JP 21038183 A JP21038183 A JP 21038183A JP S60231699 A JPS60231699 A JP S60231699A
Authority
JP
Japan
Prior art keywords
monoclonal antibody
cells
cell
antigen
atl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58210381A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0340B2 (cg-RX-API-DMAC7.html
Inventor
Toshitada Takahashi
利忠 高橋
Ryuzo Ueda
龍三 上田
Kazuo Oota
和雄 太田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AICHIKEN
Aichi Prefecture
Original Assignee
AICHIKEN
Aichi Prefecture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AICHIKEN, Aichi Prefecture filed Critical AICHIKEN
Priority to JP58210381A priority Critical patent/JPS60231699A/ja
Priority to GB08517441A priority patent/GB2163178B/en
Priority to DE19843490527 priority patent/DE3490527T/de
Priority to US06/758,224 priority patent/US4855235A/en
Priority to DE3490527A priority patent/DE3490527C2/de
Priority to PCT/JP1984/000120 priority patent/WO1985002188A1/ja
Publication of JPS60231699A publication Critical patent/JPS60231699A/ja
Publication of JPH0340B2 publication Critical patent/JPH0340B2/ja
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/112—
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3061—Blood cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864—Monoclonal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
JP58210381A 1983-11-09 1983-11-09 正常及び悪性ヒト造血器細胞に対するモノクローナル抗体 Granted JPS60231699A (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP58210381A JPS60231699A (ja) 1983-11-09 1983-11-09 正常及び悪性ヒト造血器細胞に対するモノクローナル抗体
GB08517441A GB2163178B (en) 1983-11-09 1984-03-23 Novel monoclonal antibody
DE19843490527 DE3490527T (de) 1983-11-09 1984-03-23 Neue monoklonale Antikörper
US06/758,224 US4855235A (en) 1983-11-09 1984-03-23 Monoclonal antibodies to human leukocyte antigens
DE3490527A DE3490527C2 (cg-RX-API-DMAC7.html) 1983-11-09 1984-03-23
PCT/JP1984/000120 WO1985002188A1 (fr) 1983-11-09 1984-03-23 Nouvel anticorps monoclonal

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58210381A JPS60231699A (ja) 1983-11-09 1983-11-09 正常及び悪性ヒト造血器細胞に対するモノクローナル抗体

Publications (2)

Publication Number Publication Date
JPS60231699A true JPS60231699A (ja) 1985-11-18
JPH0340B2 JPH0340B2 (cg-RX-API-DMAC7.html) 1991-01-07

Family

ID=16588395

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58210381A Granted JPS60231699A (ja) 1983-11-09 1983-11-09 正常及び悪性ヒト造血器細胞に対するモノクローナル抗体

Country Status (5)

Country Link
US (1) US4855235A (cg-RX-API-DMAC7.html)
JP (1) JPS60231699A (cg-RX-API-DMAC7.html)
DE (2) DE3490527T (cg-RX-API-DMAC7.html)
GB (1) GB2163178B (cg-RX-API-DMAC7.html)
WO (1) WO1985002188A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0325489B1 (en) * 1988-01-21 1994-01-19 Becton, Dickinson and Company Leu 23: Monoclonal antibody for monitoring leukocyte activation
FR2634126B1 (fr) * 1988-07-13 1992-04-17 Unicet Laboratoires Anticorps monoclonal specifique pour un antigene de surface des cellules b activees et/ou des cellules t transformees par l'htlv-i, lignee de cellules d'hybridomes produisant cet anticorps, procede pour la detection de cellules t transformees par l'htlv-i et/ou de cellules b activees
US6342369B1 (en) * 1997-05-15 2002-01-29 Genentech, Inc. Apo-2-receptor
PT981618E (pt) * 1997-05-15 2007-11-23 Genentech Inc ''anticorpo anti-apo-2''
US20100152426A1 (en) * 1997-05-15 2010-06-17 Ashkenazi Avi J Apo-2 receptor fusion proteins
US6252050B1 (en) * 1998-06-12 2001-06-26 Genentech, Inc. Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method
WO1999064461A2 (en) * 1998-06-12 1999-12-16 Genentech, Inc. Monoclonal antibodies, cross-reactive antibodies and method for producing the same
AUPR177400A0 (en) * 2000-11-29 2000-12-21 Cancerprobe Pty Ltd Probes for identifying cancer-specific antigens

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55127321A (en) * 1979-03-20 1980-10-02 Ortho Pharma Corp Crosssfertilization cell* antibody and method for manufacturing antibody against human t cell
JPS55145617A (en) * 1979-04-26 1980-11-13 Ortho Pharma Corp Hybrid cell line* antibody and method for manufacturing complementtfixing monoclonal antibody against human t cell
JPS5695122A (en) * 1979-12-04 1981-08-01 Ortho Pharma Corp Hybrid cell line* antibody and method for manufacturing monoclonal antibody to human early thymocyte cell
JPS5695123A (en) * 1979-12-04 1981-08-01 Ortho Pharma Corp Hybrid cell line* antibody and method for manufacturing monoclonal antibody to human prothymocyte cell
JPS56103115A (en) * 1980-01-08 1981-08-18 Ortho Pharma Corp Hybrid cell line* antibody and method for manufacturing monoclonal antibody to human t cell antigen

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515894A (en) * 1979-03-20 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to human T cells
US4515893A (en) * 1979-04-26 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells
US4515895A (en) * 1979-04-26 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to human helper T cells
US4381295A (en) * 1979-04-26 1983-04-26 Ortho Pharmaceutical Corporation Monoclonal antibody to human helper T cells and methods of preparing same
US4637983A (en) * 1979-10-09 1987-01-20 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to human cytotoxic and suppressor T cells, antibody, and methods
US4364933A (en) * 1979-12-04 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human thymocyte antigen and methods of preparing same
US4614720A (en) * 1980-01-08 1986-09-30 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to a human T cell antigen, antibody, and methods
US4364936A (en) * 1980-01-08 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human monocyte antigen and methods of preparing same
JPH0611235B2 (ja) * 1980-04-11 1994-02-16 セルテック・リミテッド モノクロ−ナル抗体
IL62965A0 (en) * 1980-07-17 1981-07-31 Scripps Miles Lab Inc Monoclonal antibodies to drugs and theri production
NO820248L (no) * 1981-01-28 1982-07-29 Coats Patons Plc Fremgangsmaate ved fremstilling av monoklone antistoffer og celler istand til aa produsere slike antistoffer
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
US4550086A (en) * 1983-02-16 1985-10-29 Dana-Farber Cancer Institute, Inc. Monoclonal antibodies that recognize human T cells
US4642925A (en) * 1985-11-22 1987-02-17 International Radiology Systems, Inc. X-ray film mount

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55127321A (en) * 1979-03-20 1980-10-02 Ortho Pharma Corp Crosssfertilization cell* antibody and method for manufacturing antibody against human t cell
JPS55145617A (en) * 1979-04-26 1980-11-13 Ortho Pharma Corp Hybrid cell line* antibody and method for manufacturing complementtfixing monoclonal antibody against human t cell
JPS5695122A (en) * 1979-12-04 1981-08-01 Ortho Pharma Corp Hybrid cell line* antibody and method for manufacturing monoclonal antibody to human early thymocyte cell
JPS5695123A (en) * 1979-12-04 1981-08-01 Ortho Pharma Corp Hybrid cell line* antibody and method for manufacturing monoclonal antibody to human prothymocyte cell
JPS56103115A (en) * 1980-01-08 1981-08-18 Ortho Pharma Corp Hybrid cell line* antibody and method for manufacturing monoclonal antibody to human t cell antigen

Also Published As

Publication number Publication date
US4855235A (en) 1989-08-08
WO1985002188A1 (fr) 1985-05-23
DE3490527T (de) 1985-11-14
DE3490527C2 (cg-RX-API-DMAC7.html) 1993-08-26
GB2163178A (en) 1986-02-19
GB2163178B (en) 1987-10-14
GB8517441D0 (en) 1985-08-14
JPH0340B2 (cg-RX-API-DMAC7.html) 1991-01-07

Similar Documents

Publication Publication Date Title
FI75183B (fi) Foerfarande foer framstaellning av en komplement-bindande monoklonal antikropp mot maenniskans t-celler genom anvaendning av en ny hybridcellinje.
Anderson et al. A monoclonal antibody with reactivity restricted to normal and neoplastic plasma cells.
US4515893A (en) Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells
EP0018794B1 (en) Monoclonal antibody to human helper t cells, method of preparing it, hybrid cell line producing it, its diagnostic and therapeutic uses and diagnostic and therapeutic compositions comprising it
FI75362C (fi) Foerfarande foer framstaellning av en monoklonal antikropp mot maenniskans t-celler, medelst en ny hybridcellinje.
US4658019A (en) Complement-fixing monoclonal antibody to human T cells
DK153954B (da) Fremgangsmaade til fremstilling af et monoklonalt antistof, hybridomacellelinie til anvendelse ved fremgangsmaaden samt fremgangsmaade til diagnose og diagnostisk praeparat med det fremstillede monoklonale antistof
BE1000611A5 (fr) Anticorps monoclonaux et antigene du carcinome pulmonaire humain a cellules non petites et de certains autres carcinomes humains.
JPS5883632A (ja) モノクロナ−ル抗体およびその製造方法
CA1201396A (en) Process for the preparation of permanent animal and human cell lines and their use
DK153891B (da) Fremgangsmaade til fremstilling af et monoklonalt antistof, hybridomacellelinie til anvendelse ved fremgangsmaaden samt fremgangsmaade til diagnose og diagnostisk praeparat med det fremstillede monoklonale antistof
JPS60231699A (ja) 正常及び悪性ヒト造血器細胞に対するモノクローナル抗体
EP0216854B1 (en) Monoclonal antibodies and assay
US5677182A (en) Cleavage site blocking antibody to prohormone proteins and uses thereof
US4818689A (en) Late differentiation antigen associated with helper T lymphocyte function
JPS6128000A (ja) ヒトｎｋ細胞溶解可能なモノクロ−ナル抗体
US5330896A (en) Monoclonal antibodies to an autocrine growth factor antigen that binds to activated lymphocytes and cancer cells
Pirtskhalava et al. Use of monoclonal antibodies (mAbs) and their future prospects
YOSHIKAWA et al. Human monoclonal antibody reactive to stomach cancer produced by mouse-human hybridoma technique
JPS60208925A (ja) ガン診断と治療のためのモノクロ−ナル抗体の生産法
JPH05506241A (ja) ３５ｋｄ腫瘍関連タンパク質抗原および免疫複合体
HRP940809A2 (en) Hybrid cell line for producing complement-fixing monoclonal antibody to human t cells, antibody and methods
JPH06319585A (ja) 抗体およびその製造法
JPH01243986A (ja) 抗ヒト固形癌ヒトモノクローナル抗体，抗体産生ハイブリドーマおよび抗体の製造法
SI8012392A8 (sl) Postopek za pridobivanje monoklonalnega protitelesa